SciSparc Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
November 29, 2022 08:00 ET | SciSparc Ltd
Tel-Aviv, Nov. 29, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the...
MoKa new logo for Globe Newswire.png
SHAREHOLDER ALERT: Morris Kandinov Investigating FOX, CEM, LBAI, and PVBC; Shareholders are Encouraged to Contact the Firm
November 29, 2022 06:00 ET | Morris Kandinov, LLP
SAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Fox Corporation, ClearBridge MLP and Midstream Fund Inc., Lakeland Bancorp, Inc., and Provident...
High Sierra Technologies, Inc. Announces Joint Venture with Hempacco Co., Inc. to Produce, Market, and Sell Hemp Cigarettes
November 28, 2022 09:15 ET | High Sierra Technologies Inc.
Reno, Nevada, Nov. 28, 2022 (GLOBE NEWSWIRE) -- On November 17, 2022, the Company’s wholly-owned subsidiary, High Sierra Technologies, Inc., a Nevada corporation (OTCQB: HSTI) (“HSTI”), executed a...
Nasdaq Leverages HashiCorp Solutions to Support Accelerated Path to the Cloud
November 22, 2022 14:20 ET | HashiCorp, Inc.
SAN FRANCISCO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- HashiCorp, Inc. (NASDAQ: HCP), a leading provider of multi-cloud infrastructure automation software, today announced that Nasdaq, a global technology...
Kraig Biocraft Laboratories Completes Closeout of $8 Million Financing, Extinguishing All Convertible Debentures with Yorkville Advisors
November 21, 2022 07:05 ET | Kraig Biocraft Laboratories
ANN ARBOR, Mich., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and...
Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
November 17, 2022 11:43 ET | Clearmind Medicine Inc.
VANCOUVER, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of...
DI 400 x 400  copy jpeg.jpg
Circulating Tumor Cell Diagnostics Market Forecast to Rise Over Next 7 Years - Compare the report on Douglas Insights
November 16, 2022 07:19 ET | Douglas Insights
DOUGLAS, Isle of Man, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Circulating tumour cell diagnosis and testing are becoming more common. It enables medical professionals to detect and quantify the tumour...
Totaligent Reaches Major Artificial Intelligence Milestone
November 15, 2022 08:05 ET | Totaligent, Inc.
BOCA RATON, Fla., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Totaligent, Inc. (“Totaligent” or “the Company”) (OTCPK: TGNT) announces it has completed testing of its scalable Nvidia clusters and has started...
HEXO and Entourage Health Sign Long-Term Supply Agreement
November 15, 2022 07:30 ET | HEXO Corp.
This news release constitutes a “designated news release” for the purposes of HEXO’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and...
Kraig Biocraft Laboratories poised to Close Out Yorkville Convertible Debenture with Strongest Financial Position in Corporate History
November 15, 2022 07:05 ET | Kraig Biocraft Laboratories
ANN ARBOR, Mich., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), the biotechnology company focused on the development and...